Anti-malarial prescriptions in three health care facilities after the emergence of chloroquine resistance in Niakhar, Senegal (1992–2004)

Table 1 Anti-malarial prescriptions to all patients, presumptive malarial and non-malarial patients.

	no of prescribed AM*	%	no of patients receiving AM	%	malarial patients	%	non-malarial patients^§	%
total AM*	73 779	100	53 391	100	39 998	74.9	12 656	23.7
CQ ¹ (total)	41 103	55.7	41 103	77.0	29 452	71.7	11 058	26.9
Q ² (total)	25 546	34.6	25 546	47.8	23 783	93.1	1 570	6.1
CQ+Q ³	16 391	22.2	16 391	30.7	15 608	95.2	717	4.4
SP ⁴ (total)	3 785	5.1	3 785	7.1	3 275	86.5	487	12.9
AQ ⁵ (total)	3 335	4.5	3 335	6.2	2 845	85.3	487	14.6
AQ+SP ⁶	1 828	2.5	1 828	3.4	1 658	90.7	168	9.2

*AM: Anti-malarials, ^§patients with unknown clinical diagnosis are excluded.
¹CQ (total): total number of chloroquine treatments (CQ prescribed alone and CQ+Q), ²Q (total): total number of quinine treatments (Q prescribed alone and CQ+Q), ³CQ+Q: CQ and Q prescribed together (Q as first treatment and CQ as relay treatment), ⁴SP (total): total number of sulphadoxine-pyrimethamine treatments, ⁵AQ (total): total number of amodiaquine treatments, ⁶AQ+SP: bi-therapy with AQ and SP.

ISSN: 1475-2875